Useful Links
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
From – National Intelligence Report
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published…
G2 Blog
Diagnostic danger in the lab: Time to reform how we process orders
By Oleg Bess, M.D. bio
I don’t know about you, but I was stunned by the findings from a recent report published by Coverys, a national liability insurer, which I feel should…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From – Laboratory Industry Report
Agilent, Bio-Techne and Mission Bio were among the producers launching multiple products. Here’s a rundown of the key diagnostic product launches from…
Expanded Carrier Screening IDs Rare Variants in Diverse Populations
From – Diagnostic Testing & Emerging Technologies
Expanded next-generation sequencing-based carrier screening improves detection of rare and novel pathogenic variants even in…
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
From – G2 Compliance Advisor
Case: The feds accused a Missouri lab of submitting false claims to Medicare for travel fees in transporting specimens from April 2011 to December 2014. In addition…
Enforcement Trends: Private Insurers Are Cracking Down on the Labs that Scam Them
From – National Intelligence Report
Once the almost exclusive domain of federal law enforcers and inside whistleblowers, the lucrative industry of going after labs for improper billing has…